News and Info

Welcome to the News and Info section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed about the latest news and ongoing activities of the organization. This section contains announcements, news stories, press releases, and blogs.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

March 23, 2023
March 23, 2023
Categories

The Spring 2023 advocacy blog Considering Clinical Trials is now available

Do you like it?
Read more
March 21, 2023
March 21, 2023
Categories

In this video interview, Dr. Neha Vapiwala discusses the INDICATE (EA8191) trial and changing the trajectory of prostate cancer through radiation and imaging techniques

Do you like it?
Read more
March 8, 2023
March 8, 2023
Categories

The ComboMATCH patient registration trial and three treatment trials are now open

Do you like it?
Read more
February 27, 2023
February 27, 2023
Categories

The TAILORx trial continues to provide reassurance that many women with early breast cancer can safely forego chemotherapy

Do you like it?
Read more
February 23, 2023
February 23, 2023
Categories

A focus on the DREAMseq trial reveals data-driven clinical insights into the selection of first-line treatment options for patients with BRAF-mutated metastatic melanoma

Do you like it?
Read more
February 15, 2023
February 15, 2023
Categories

A participant in the E1910 trial shares her experience in a Penn Medicine feature story with her hematologist, Dr. Selina Luger

Do you like it?
Read more
February 15, 2023
February 15, 2023
Categories

ASCO Living Guideline says ‘no’ to anti-VEGF-chemo combo in non-small cell lung cancer without driver alterations, based on data from the E5508 trial

Do you like it?
Read more
February 10, 2023
February 10, 2023
Categories

The January/February 2023 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
February 10, 2023
February 10, 2023
Categories

ECOG-ACRIN announces the Remarkable Mentor to Women in Oncology Award (nominations are due March 9)

Do you like it?
Read more
February 9, 2023
February 9, 2023
Categories

The application period is now open for Spring Meeting Attendance Awards for minority trainees

Do you like it?
Read more
February 6, 2023
February 6, 2023
Categories

Ongoing Trial: The INSIGNA clinical trial is testing the timing of immunotherapy alone or with chemotherapy for patients with advanced lung cancer

Do you like it?
Read more
February 1, 2023
February 1, 2023
Categories

Ongoing Trial: The INSPIRE research study is testing a new treatment approach for patients with advanced bladder cancer

Do you like it?
Read more
January 30, 2023
January 30, 2023
Categories

Now Enrolling: The BRIDGE research study is evaluating a new treatment approach for patients with early bladder cancer

Do you like it?
Read more
January 24, 2023
January 24, 2023
Categories

Blinatumomab significantly improves overall survival in newly diagnosed B-ALL patients who are MRD-negative after initial treatment (study E1910)

Do you like it?
Read more
January 5, 2023
January 5, 2023
Categories

The Winter 2023 advocacy blog Considering Clinical Trials is now available

Do you like it?
Read more
December 20, 2022
December 20, 2022
Categories

The November/December 2022 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
December 19, 2022
December 19, 2022
Categories

Blinatumomab Plus Consolidation Chemotherapy Significantly Reduces Risk of Death in MRD-Negative B-Cell ALL

Do you like it?
Read more
December 15, 2022
December 15, 2022
Categories

Study E1910 consolidates the role of blinatumomab in acute lymphoblastic leukemia (ALL)

Do you like it?
Read more
December 14, 2022
December 14, 2022
Categories

Blinatumomab further improves survival among patients with B-ALL and a good prognosis (study E1910)

Do you like it?
Read more
December 13, 2022
December 13, 2022
Categories

Immunotherapy Plus Consolidation Chemo Improves Survival in B Lineage ALL

Do you like it?
Read more
Load more
News and Info

About Us Home Page

News and Info
Media Contact:
Diane Dragaud, MA
Director of Communications

Send an email

215-789-3631

Categories


Tags

Acute lymphoblastic leukemia Acute myeloid leukemia Advocacy Bladder cancer Breast cancer Cancer screening Cancer surveillance Cancer treatment Care delivery Chronic lymphocytic leukemia Clinical trial Disparities Genomic testing GI cancer Group meeting Head and neck cancer Health equity Immunotherapy INSPIRE Leadership Leukemia Lung cancer Lymph nodes Mammography Melanoma Mentorship Multiple myeloma Myelodysplastic syndrome Myeloma NCI-MATCH Pancreatic cancer Pancreatic cysts Personalized screening Personalized treatment Precision medicine Prostate cancer Research results Skin cancer Social determinants of health Survivorship Symptom control TAILORx Targeted therapy TMIST Treatment trial

 
ECOG-ACRIN Cancer Research Group